Assignee
EXCALIARD PHARMACEUTICALS INC
US·1 granted patent·3 pending applications·0 citations·filing 2015–2018
Top patents by PatentIndex Score
4 records- 0159US2019323013A1Antisense oligonucleotides directed against connective tissue growth factor and uses thereofEXCALIARD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0255US2017335329A1Antisense oligonucleotides directed against connective tissue growth factor and uses thereofEXCALIARD PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0352US9688987B2Antisense oligonucleotides directed against connective tissue growth factor and uses thereofEXCALIARD PHARMACEUTICALS INC·Filed 2015·Granted Jun 27, 2017·0 cites·59 claims
- 0437US2017022501A1Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf)EXCALIARD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →